As opposed to controls, tumor tissues from IL-33-treated mice displayed the substantial presence of degranulating tumor-infiltrating eosinophils within tumor necrotic areas, as revealed by co-expression of Siglec-F with EPX (Figure 6A, Figure S6) and granzyme-B (Figure 6B, Figure S7). Here, IL33 is linked to neoplasm.